Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |